|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 106.64 CHF | -0.41% |
|
+2.28% | +20.23% |
| 02:29am | AlphaValue/Baader Europe Ups Novartis Price Target on 'Strong' Execution, 'Vigorous' Growth | MT |
| 02:01am | NOVARTIS AG : Upgraded to Buy by JP Morgan | ZD |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 255B | |||||
| 905B | |||||
| 487B | |||||
| 400B | |||||
| 330B | |||||
| 281B |
- Stock Market
- Equities
- NOVN Stock
- Charts Novartis AG
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
